Last reviewed · How we verify
Staphylococcus Aureus Bronchitis
Approved treatments
- Methocillin S · GSK
- ALATROFLOXACIN · Pfizer
- Sparcin
- Noroxin
- Floxin
- Pathocil · Pfizer
- Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - Bactocill In Plastic Container · Apothecon
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Staphylococcus Aureus Bronchitis patent landscape — cliff calendar, originator estates, attackable patents
- Staphylococcus Aureus Bronchitis treatment landscape brief
- Staphylococcus Aureus Bronchitis treatment updates RSS
Frequently asked questions about Staphylococcus Aureus Bronchitis
What drugs treat Staphylococcus Aureus Bronchitis?
Tracked treatments include Methocillin S, ALATROFLOXACIN, Sparcin, Noroxin, Floxin, Pathocil, Levaquin, Bactocill In Plastic Container.
What is the treatment for Staphylococcus Aureus Bronchitis?
Standard treatment for Staphylococcus Aureus Bronchitis includes Methocillin S, ALATROFLOXACIN, Sparcin, Noroxin, Floxin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Staphylococcus Aureus Bronchitis patent cliff · Staphylococcus Aureus Bronchitis CI report
- Treatment: Methocillin S · GSK
- Treatment: ALATROFLOXACIN · Pfizer
- Treatment: Sparcin
- Treatment: Noroxin
- Treatment: Floxin
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing